» Articles » PMID: 36581942

LncRNA ZNRD1-AS1 Promotes Malignant Lung Cell Proliferation, Migration, and Angiogenesis Via the MiR-942/TNS1 Axis and is Positively Regulated by the MA Reader YTHDC2

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2022 Dec 29
PMID 36581942
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Lung cancer is the most prevalent form of cancer and has a high mortality rate, making it a global public health concern. The N-methyladenosine (mA) modification is a highly dynamic and reversible process that is involved in a variety of essential biological processes. Using in vitro, in vivo, and multi-omics bioinformatics, the present study aims to determine the function and regulatory mechanisms of the long non-coding (lnc)RNA zinc ribbon domain-containing 1-antisense 1 (ZNRD1-AS1).

Methods: The RNAs that were bound to the mA 'reader' were identified using YTH domain-containing 2 (YTHDC2) RNA immunoprecipitation (RIP)-sequencing. Utilizing methylated RIP PCR/quantitative PCR, pull-down, and RNA stability assays, mA modification and ZNRD1-AS1 regulation were analyzed. Using bioinformatics, the expression levels and clinical significance of ZNRD1-AS1 in lung cancer were evaluated. Using fluorescent in situ hybridization and quantitative PCR assays, the subcellular location of ZNRD1-AS1 was determined. Using cell migration, proliferation, and angiogenesis assays, the biological function of ZNRD1-AS1 in lung cancer was determined. In addition, the tumor suppressor effect of ZNRD1-AS1 in vivo was validated using a xenograft animal model. Through bioinformatics analysis and in vitro assays, the downstream microRNAs (miRs) and competing endogenous RNAs were also predicted and validated.

Results: This study provided evidence that mA modification mediates YTHDC2-mediated downregulation of ZNRD1-AS1 in lung cancer and cigarette smoke-exposed cells. Low levels of ZNRD1-AS1 expression were linked to adverse clinicopathological characteristics, immune infiltration, and prognosis. ZNRD1-AS1 overexpression was shown to suppress lung cancer cell proliferation, migration, and angiogenesis in vitro and in vivo, and to reduce tumor growth in nude mice. ZNRD1-AS1 expression was shown to be controlled by treatment of cells with either the methylation inhibitor 3-Deazaadenosine or the demethylation inhibitor Meclofenamic. Furthermore, the miR-942/tensin 1 (TNS1) axis was demonstrated to be the downstream regulatory signaling pathway of ZNRD1-AS1.

Conclusions: ZNRD1-AS1 serves an important function and has clinical relevance in lung cancer. In addition, the findings suggested that mA modification could mediate the regulation of the ZNRD1-AS1/miR-942/TNS1 axis via the mA reader YTHDC2.

Citing Articles

The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.

Xie X, Fang Z, Zhang H, Wang Z, Li J, Jia Y EXCLI J. 2025; 24:113-150.

PMID: 39967906 PMC: 11830918. DOI: 10.17179/excli2024-7935.


Integrating single-cell sequencing and machine learning to uncover the role of mitophagy in subtyping and prognosis of esophageal cancer.

Tian F, He X, Wang S, Liang Y, Wang Z, Hu M Apoptosis. 2025; .

PMID: 39948301 DOI: 10.1007/s10495-024-02061-1.


The therapeutic potential of RNA m(6)A in lung cancer.

Yu J, Sun W, Zhao X, Chen Y Cell Commun Signal. 2024; 22(1):617.

PMID: 39736743 PMC: 11687105. DOI: 10.1186/s12964-024-01980-5.


The role of N6-methyladenosine modification in tumor angiogenesis.

Qin L, Zeng X, Qiu X, Chen X, Liu S Front Oncol. 2024; 14:1467850.

PMID: 39691597 PMC: 11649548. DOI: 10.3389/fonc.2024.1467850.


Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism.

Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F Theranostics. 2024; 14(18):7088-7110.

PMID: 39629121 PMC: 11610135. DOI: 10.7150/thno.99197.


References
1.
Chen H, Duncan I, Bozorgchami H, Lo S . Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. Proc Natl Acad Sci U S A. 2002; 99(2):733-8. PMC: 117374. DOI: 10.1073/pnas.022518699. View

2.
Flanders W, Lally C, Zhu B, Henley S, Thun M . Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res. 2003; 63(19):6556-62. View

3.
Dunn G, Old L, Schreiber R . The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21(2):137-48. DOI: 10.1016/j.immuni.2004.07.017. View

4.
Wang M, Yang C, Liu X, Zheng J, Xue Y, Ruan X . An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway. J Cell Mol Med. 2020; 24(11):6120-6136. PMC: 7294115. DOI: 10.1111/jcmm.15217. View

5.
Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S . Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012; 485(7397):201-6. DOI: 10.1038/nature11112. View